CY1124940T1 - Αλας διμεθυλαμινοαιθανολης ενος ρυθμιστη του υποδοχεα glp-1 - Google Patents
Αλας διμεθυλαμινοαιθανολης ενος ρυθμιστη του υποδοχεα glp-1Info
- Publication number
- CY1124940T1 CY1124940T1 CY20211101089T CY211101089T CY1124940T1 CY 1124940 T1 CY1124940 T1 CY 1124940T1 CY 20211101089 T CY20211101089 T CY 20211101089T CY 211101089 T CY211101089 T CY 211101089T CY 1124940 T1 CY1124940 T1 CY 1124940T1
- Authority
- CY
- Cyprus
- Prior art keywords
- glp
- receptor regulator
- dimethylaminoethanol salt
- salt
- dimethylaminoethanol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Κρυσταλλικό άλας 1-(2-(5-(tert-βουτυλο)-θειοφαινο-2-καρβοξαμιδο)-3-(4-(5-( 4'-αιθυλο-[1,1'-δι(κυκλοεξαν)]-3-εν-4-υλο)πυριμιδιν-2-υλο)φαινυλο)προπανοϋλο)αζετιδινο-3-καρβοξυλικού 2-υδροξυ-Ν,Ν-διμεθυλαιθαναμινίου και μέθοδοι που σχετίζονται με τη σύνθεση και τη θεραπευτική χρήση αυτού.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662402565P | 2016-09-30 | 2016-09-30 | |
PCT/US2017/054298 WO2018064476A1 (en) | 2016-09-30 | 2017-09-29 | Dimethylaminoethanol salt of a glp-1 receptor modulator |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1124940T1 true CY1124940T1 (el) | 2023-01-05 |
Family
ID=60043396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20211101089T CY1124940T1 (el) | 2016-09-30 | 2021-12-10 | Αλας διμεθυλαμινοαιθανολης ενος ρυθμιστη του υποδοχεα glp-1 |
Country Status (12)
Country | Link |
---|---|
US (1) | US11066395B2 (el) |
EP (1) | EP3519407B1 (el) |
CY (1) | CY1124940T1 (el) |
ES (1) | ES2901599T3 (el) |
HR (1) | HRP20211938T1 (el) |
HU (1) | HUE056805T2 (el) |
LT (1) | LT3519407T (el) |
PL (1) | PL3519407T3 (el) |
PT (1) | PT3519407T (el) |
RS (1) | RS62814B1 (el) |
SI (1) | SI3519407T1 (el) |
WO (1) | WO2018064476A1 (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113166056A (zh) * | 2018-11-28 | 2021-07-23 | 罗欣药业(上海)有限公司 | 一种雌激素受体下调剂的盐型、晶型及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107074820B (zh) * | 2014-07-25 | 2021-05-18 | 赛尔基因第二国际有限公司 | Glp-1受体调节剂 |
-
2017
- 2017-09-29 PT PT177813474T patent/PT3519407T/pt unknown
- 2017-09-29 ES ES17781347T patent/ES2901599T3/es active Active
- 2017-09-29 HR HRP20211938TT patent/HRP20211938T1/hr unknown
- 2017-09-29 HU HUE17781347A patent/HUE056805T2/hu unknown
- 2017-09-29 LT LTEPPCT/US2017/054298T patent/LT3519407T/lt unknown
- 2017-09-29 EP EP17781347.4A patent/EP3519407B1/en active Active
- 2017-09-29 WO PCT/US2017/054298 patent/WO2018064476A1/en unknown
- 2017-09-29 US US16/337,298 patent/US11066395B2/en active Active
- 2017-09-29 PL PL17781347T patent/PL3519407T3/pl unknown
- 2017-09-29 RS RS20211553A patent/RS62814B1/sr unknown
- 2017-09-29 SI SI201731018T patent/SI3519407T1/sl unknown
-
2021
- 2021-12-10 CY CY20211101089T patent/CY1124940T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20211938T1 (hr) | 2022-03-18 |
PT3519407T (pt) | 2021-12-10 |
ES2901599T3 (es) | 2022-03-23 |
LT3519407T (lt) | 2022-01-10 |
US20200131164A1 (en) | 2020-04-30 |
HUE056805T2 (hu) | 2022-03-28 |
WO2018064476A1 (en) | 2018-04-05 |
US11066395B2 (en) | 2021-07-20 |
EP3519407A1 (en) | 2019-08-07 |
PL3519407T3 (pl) | 2022-02-14 |
RS62814B1 (sr) | 2022-02-28 |
EP3519407B1 (en) | 2021-09-22 |
SI3519407T1 (sl) | 2022-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017000705A1 (es) | Nuevos compuestos | |
CY1120611T1 (el) | Κρυσταλλικες μορφες 1-(5'-(5-(3,5-διχλωρο-4-φθοροφαινυλο)-5-(τριφθορομεθυλο)-4,5-διυδροϊσοξαζολ-3-υλο)-3ή-σπειρο[αζετιδιν-3,1'-ισοβενζοφουραν]-1-υλο)-2-(μεθυλοσουλφονυλ)αιθανονης | |
PE20220253A1 (es) | Benzamidas sustituidas con 1,3-tiazol-2-ilo | |
MX2022013949A (es) | Derivados heterociclicos condensados sustituidos por 2-(het)arilo como pesticidas. | |
CL2019000397A1 (es) | Proceso para preparar el compuesto n-((s)-1-(3-(3-cloro -4-cianofenil)-1h-pirazol-1-il)-5-(1-hidroxi-etil)-1h-pirazol-3-carboxamida de la formula (1a).(divisional solicitud 201702491) | |
DOP2013000072A (es) | ((r)-(e)-2-(4-(2-(5-(1-(3,5-dicloropiridin-4-il)etoxi)-1h-indazol-3-il)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol cristalino. | |
PE20160843A1 (es) | Pirrolidinonas herbicidas | |
NI201900053A (es) | Formas cristalinas de un inhibidor de magl | |
UA122520C2 (uk) | Кристалічна форма 2-[4-(4-хлорфенокси)-2-(трифторметил)феніл]-1-(1,2,4-триазол-1-іл)пропан-2-олу, агрохімічна композиція, застосування та спосіб боротьби зі шкідливими грибами | |
MX2020008367A (es) | Formas cristalinas novedosas. | |
PE20091673A1 (es) | Nuevos derivados de carbazol, inhibidores de hsp90, composiciones que los contienen y utilizacion | |
PE20170705A1 (es) | Nuevos compuestos como inhibidores de ret (reorganizado durante la transfeccion) | |
NZ629636A (en) | Liver x receptor (lxr) modulators for the treatment of dermal diseases, disorders and conditions | |
GB201609607D0 (en) | Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts | |
AR086913A1 (es) | 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]-amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil]-benzamida amorfa, forma de dosificacion que la contiene y metodo para prepararlas | |
CO6450624A2 (es) | Compuestos vinil indazolilo | |
PE20191108A1 (es) | Inhibidores selectivos de jak1 | |
PL3464276T3 (pl) | Nowa postać krystaliczna n-[5-(3,5-difluoro-benzylo)-1h-indazol-3-ilo)-4-(4-metylopiperazyn-1-ylo)-2-tetrahydropiran-4-yloamino)-benzamidu | |
AR111469A1 (es) | Sal de un compuesto del derivado de aminopiridina, una forma cristalina de la misma, y un proceso para preparar la misma | |
MX2018009790A (es) | 2-(het)arilimidazolilcarboxiamidas sustituidas como pesticidas. | |
MX2022007105A (es) | Formas solidas de sal de 1,3-dihidroxi-2-(hidroximetil)propan-2-am ina de acido 2-((4-((s)-2-(5-cloropiridin-2-il)-2-metilbenzo[d][1, 3] dioxol-4-il)piperidin-1-il)metil)-1-(((s)-oxetan-2-il) metil)-1h- benzo[d]imidazol-6-carboxilico. | |
CL2015002309A1 (es) | Proceso de fabricacion de vortioxetina. | |
MA53605A (fr) | Composés d'isoxazoline pour lutter contre des invertébrés nuisibles | |
CY1124940T1 (el) | Αλας διμεθυλαμινοαιθανολης ενος ρυθμιστη του υποδοχεα glp-1 | |
NZ735783A (en) | Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof. |